IRCT2017061018974N3已完成1 期
Evaluation of probiotics effects on bilirubin level in patient with neonatal jaundice admitted in the hospital
Deputy Minister for Research and Technology0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 day 至 10 days（—）
- 性别
- All
入选标准
- •term infants with age between 3-10 days and gestational age of 42-37 weeks , birth weight equals or more than 2500 g , and bilirubin 12.9-up mg / dL at the start of phototherapy, and fed only by breast milk.Exclusion criteria: infants with blood disorders family, having signs of hemolysis due to blood group incompatibility, internal bleeding indoors due to complications of traumatic birth (exp : cephalohematom), suspected neonatal infection such as chorioamnionitis, intrauterine infection, sepsis and urinary tract infection, perinatal hypoxic newborns, having thyroid dysfunction, distress or respiratory failure, malfunction regulate body temperature and metabolic, hemodynamic instability and congenital heart disease, a history of maternal use of phenobarbital during the last month of pregnancy venous hematocrit 65%
排除标准
- 未提供
研究者
相似试验
招募中
3 期
The effect of probiotics on indirect bilirubin levelsJaundice in babies.Neonatal jaundice, unspecifiedP59.9IRCT20180311039048N1Zanjan University of Medical Sciences120
招募中
3 期
The effect of probiotics on the prevention of bacterial biofilm formation on double Jrinary tract infection.Urinary tract infection, site not specifiedN39.0IRCT20190624043991N19Tehran University of Medical Sciences108
已完成
不适用
Are probiotics beneficial for ulcerative colitis patients with poor pelvic pouch function?lcerative colitisDigestive SystemUlcerative colitisISRCTN50513887Probi AB (Sweden)30
已完成
不适用
Effect of probiotic on management of critically ill patientssepsis.Sepsis, unspecifiedIRCT201112143320N6Tabriz University of Medical Sciences40
已完成
3 期
Effect of probiotics on general mental health in healthy human volunteersCondition 1: General mental health. Condition 2: Generalized anxiety disorder.Other symptoms and signs involving appearance and behaviourGeneralized anxiety disorderIRCT2017053034246N1Vice chancellor for Research and Technology50